TLR9 and malaria: TLR9 agonists COV08-0064 and E6446, can inhibit TLR9-mediated sterile inflammation in acute liver injury and acute pancreatitis models and restrain responses of deleterious inflammation in rodent malaria, respectively 135, 136.